Original Article

You have full text access to this OnlineOpen article

Colorectal liver metastases contract centripetally with a response to chemotherapy†

A histomorphologic study

  1. Jennica K.S. Ng MD1,
  2. Stefan J. Urbanski MD2,
  3. Naurang Mangat PhD3,
  4. Andrew McKay MD1,
  5. Francis R. Sutherland MD1,
  6. Elijah Dixon MD1,
  7. Scot Dowden MD3,
  8. Scott Ernst MD4,
  9. Oliver F. Bathe MD1,3,‡,*

Article first published online: 26 NOV 2007

DOI: 10.1002/cncr.23184

Issue

Cancer

Cancer

Volume 112, Issue 2, pages 362–371, 15 January 2008

Additional Information

How to Cite

Ng, J. K.S., Urbanski, S. J., Mangat, N., McKay, A., Sutherland, F. R., Dixon, E., Dowden, S., Ernst, S. and Bathe, O. F. (2008), Colorectal liver metastases contract centripetally with a response to chemotherapy. Cancer, 112: 362–371. doi: 10.1002/cncr.23184

Author Information

  1. 1

    Department of Surgery, University of Calgary, Calgary, Alberta, Canada

  2. 2

    Department of Pathology, University of Calgary, Calgary, Alberta, Canada

  3. 3

    Department of Oncology, University of Calgary, Calgary, Alberta, Canada

  4. 4

    Department of Oncology, London Regional Cancer Centre, London, Ontario, Canada

  1. ‡

    Fax: (403) 283-1651.

*Tom Baker Cancer Centre, Division of Surgical Oncology, 1331-29th St. NW, Calgary, Alberta, Canada T2N 4N2

  1. †

    The study was reviewed and approved by the Conjoint Health Research Ethics Board of the University of Calgary.

Publication History

  1. Issue published online: 4 JAN 2008
  2. Article first published online: 26 NOV 2007
  3. Manuscript Accepted: 21 AUG 2007
  4. Manuscript Revised: 15 AUG 2007
  5. Manuscript Received: 9 MAY 2007

Funded by

  • Pfizer Canada Inc.

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (494K)

REFERENCES

  • 1
    Goldberg RM,Gill S. Recent phase III trials of fluorouracil, irinotecan, and oxaliplatin as chemotherapy for metastatic colorectal cancer. Cancer Chemother Pharmacol. 2004; 54( Suppl 1): S57–64.
  • 2
    Twelves C,Wong A,Nowacki MP, et al. Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med. 2005; 352: 2696–2704.
  • 3
    Andre T,Boni C,Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004; 350: 2343–2351.
  • 4
    Hurwitz H,Fehrenbacher L,Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004; 350: 2335–2342.
  • 5
    Colucci G,Gebbia V,Paoletti G, et al. Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale. J Clin Oncol. 2005; 23: 4866–4875.
  • 6
    Fong Y,Kemeny N,Paty P,Blumgart LH,Cohen AM. Treatment of colorectal cancer: hepatic metastasis. Semin Surg Oncol. 1996; 12: 219–252.
    Direct Link:
  • 7
    Ballantyne GH,Quin J. Surgical treatment of liver metastases in patients with colorectal cancer. Cancer. 1993; 71: 4252–4266.
    Direct Link:
  • 8
    Simmonds PC,Primrose JN,Colquitt JL,Garden OJ,Poston GJ,Rees M. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer. 2006; 94: 982–999.
  • 9
    Van CE,Nordlinger B,Adam R, et al. Towards a pan-European consensus on the treatment of patients with colorectal liver metastases. Eur J Cancer. 2006; 42: 2212–2221.
  • 10
    Masi G,Cupini S,Marcucci L, et al. Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer. Ann Surg Oncol. 2006; 13: 58–65.
  • 11
    Capussotti L,Muratore A,Mulas MM,Massucco P,Aglietta M. Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases. Br J Surg. 2006; 93: 1001–106.
    Direct Link:
  • 12
    Delaunoit T,Alberts SR,Sargent DJ, et al. Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741. Ann Oncol. 2005; 16: 425–429.
  • 13
    Bismuth H,Adam R,Levi F, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg. 1996; 224: 509–520.
  • 14
    Adam R,Avisar E,Ariche A, et al. Five-year survival after hepatic resection following neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol. 2001; 8: 347–353.
  • 15
    Pozzo C,Basso M,Cassano A, et al. Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. Ann Oncol. 2004; 15: 933–939.
  • 16
    Rivoire M,De CF,Meeus P,Gignoux B,Frering B,Kaemmerlen P. Cryosurgery as a means to improve surgical treatment of patients with multiple unresectable liver metastases. Anticancer Res. 2000; 20: 3785–3790.
  • 17
    Lorenz M,Staib-Sebler E,Gog C, et al. Prospective pilot study of neoadjuvant chemotherapy with 5-fluorouracil, folinic acid and oxaliplatin in resectable liver metastases of colorectal cancer. Analysis of 42 neoadjuvant chemotherapies. Zentralbl Chir. 2003; 128: 87–94.
  • 18
    Allen PJ,Kemeny N,Jarnagin W,DeMatteo R,Blumgart L,Fong Y. Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg. 2003; 7: 109–115.
  • 19
    Wein A,Riedel C,Bruckl W, et al. Neoadjuvant treatment with weekly high-dose 5-Fluorouracil as 24-hour infusion, folinic acid and oxaliplatin in patients with primary resectable liver metastases of colorectal cancer. Oncology. 2003; 64: 131–138.
  • 20
    Bathe OF,Dowden S,Sutherland F, et al. Phase II study of neoadjuvant 5-FU + leucovorin + CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma. BMC Cancer. 2004; 4: 32.
  • 21
    Therasse P,Arbuck SG,Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000; 92: 205–216.
  • 22
    Solaun MS,Mendoza L,De LM, et al. Endostatin inhibits murine colon carcinoma sinusoidal-type metastases by preferential targeting of hepatic sinusoidal endothelium. Hepatology. 2002; 35: 1104–1116.
    Direct Link:
  • 23
    Paku S,Lapis K. Morphological aspects of angiogenesis in experimental liver metastases. Am J Pathol. 1993; 143: 926–936.
  • 24
    Bathe OF. Preoperative chemotherapy for liver metastases: a contemporary approach giving rise to new questions. JSurg Oncol. 2004; 86: 1–3.
    Direct Link:
  • 25
    Kumar V,Fausto N,Abas A. Robbins and Cotran Pathologic Basis of Disease, 7th ed. Philadelphia: W.B. Saunders; 2004.
  • 26
    Benoist S,Brouquet A,Penna C, et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol. 2006; 24: 3939–3945.
  • 27
    Pawlik TM,Scoggins CR,Zorzi D, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005; 241: 715–722; discussion, 722–724.
  • 28
    Chen AM,Meric-Bernstam F,Hunt KK, et al. Breast conservation after neoadjuvant chemotherapy. Cancer. 2005; 103: 689–695.
    Direct Link:
  • 29
    Rouzier R,Mathieu MC,Sideris L, et al. Breast-conserving surgery after neoadjuvant anthracycline-based chemotherapy for large breast tumors. Cancer. 2004; 101: 918–925.
    Direct Link:
  • 30
    Sauer R,Becker H,Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. NEngl J Med. 2004; 351: 1731–1740.
  • 31
    Elias D,Youssef O,Sideris L, et al. Evolution of missing colorectal liver metastases following inductive chemotherapy and hepatectomy. J Surg Oncol. 2004; 86: 4–9.
    Direct Link:
View Full Article (HTML) Get PDF (494K)